AVGO vs CBIO · P/E 87, rev $41.50B vs rev $1.0M
Broadcom Inc (AVGO) versus Crescent Biopharma, Inc. (CBIO) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. CBIO currently screens at market cap $491.3M.
Not investment advice. Open the AVGO and CBIO stock pages for the full models.
Not investment advice.